subscribeSubscribe
MSN`s Generic Carfilzomib Receives Approval in the U.S.

MSN`s Generic Carfilzomib Receives Approval in the U.S.
FDA
30 Jan 2023
Share Share
Eugia`s Generic Carfilzomib Receives Approval in the U.S.

Eugia`s Generic Carfilzomib Receives Approval in the U.S.
FDA
25 Nov 2022
Share Share
Sanofi reports positive Phase III multiple myeloma trial results

Sanofi reports positive Phase III multiple myeloma trial results
CLINICALTRIALSARENA
16 May 2022
Share Share
FDA Grants Approval to Janssen`s DARZALEX FASPRO + Carfilzomib & Dexamethasone

FDA Grants Approval to Janssen`s DARZALEX FASPRO + Carfilzomib & Dexamethasone
PRNEWSWIRE
01 Dec 2021
Share Share
Health Canada approves Sanofi`s Sarclisa combination for multiple myeloma

Health Canada approves Sanofi`s Sarclisa combination for multiple myeloma
Mamta Mayani SEEKINGALPHA
13 Oct 2021
Share Share
Breckenridge Announces Approval of its ANDA for Carfilzomib Intravenous Powder

Breckenridge Announces Approval of its ANDA for Carfilzomib Intravenous Powder
PRNEWSWIRE
16 Jun 2021
Share Share
Breckenridge Announces Approval of its ANDA for Carfilzomib Intravenous Powder

Breckenridge Announces Approval of its ANDA for Carfilzomib Intravenous Powder
BIOSPACE
16 Jun 2021
Share Share
NATCO receives approval for Carfilzomib Vials ANDA

NATCO receives approval for Carfilzomib Vials ANDA
BUSINESS STANDARD
14 Jun 2021
Share Share
EC approves new Sarclisa indication

EC approves new Sarclisa indication
Lucy Parsons PHARMATIMES
19 Apr 2021
Share Share
NICE recommends Kyprolis triple combination treatment for multiple myeloma

NICE recommends Kyprolis triple combination treatment for multiple myeloma
Lucy Parsons PHARMATIMES
22 Mar 2021
Share Share